Utilizing fMRI to Determine the Effects of Vyvanse on Memory, Attention, and Brain Activity in Menopausal Women

Trial Profile

Utilizing fMRI to Determine the Effects of Vyvanse on Memory, Attention, and Brain Activity in Menopausal Women

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Lisdexamfetamine (Primary)
  • Indications Cognition disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 May 2014 Trial status changed to completed as reported by ClinicalTrials.go.
    • 13 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top